mRNA Vaccine
Pfizer Collaborates with Ginkgo in a $331 Million Biobucks Partnership
Ginkgo Bioworks has secured a substantial partnership with pharmaceutical giant Pfizer, marking a significant milestone in its portfolio of collaborations. ...
Moderna axes four programs, including two former AstraZeneca collaborations
Moderna, following its recent phase 3 success with an mRNA flu vaccine, has made the decision to remove four clinical ...
CureVac selects mRNA flu vaccine candidate for GSK collaboration, but data remains secret
CureVac, the renowned biotech company, has made a significant stride in its quest to develop an mRNA influenza vaccine. While ...
Pfizer and BioNTech challenge Moderna’s mRNA vaccine patents in a bid to end monopoly
The legal battle between Moderna and its rivals Pfizer and BioNTech over the patents related to mRNA vaccine production is ...
Diversifying Strategies as Vaccine Demand Shifts: COVID-19 Vaccine Manufacturers Anticipate Fall Inoculation Season
Amidst a challenging environment of declining demand for COVID-19 vaccines, producers are eagerly awaiting the upcoming fall inoculation season as ...
Japanese Government Backs Arcalis with $115 Million Grants for mRNA Vaccine Production
Following Daiichi Sankyo’s recent accomplishment of securing Japan’s first mRNA vaccine approval, a potential competitor has emerged backed by significant ...
Moderna Application For FDA Approval Of Updated Covid-19 Vaccine
Source – Moderna On June 22, 2023, a regulatory application for Moderna’s updated COVID-19 mRNA vaccine (mRNA-1273.815), which contains spike ...
Comprehensive Guide to mRNA Vaccines: Advancements in COVID-19 Immunization
Introduction At our organization, we are dedicated to providing valuable information on the latest advancements in COVID-19 vaccines. In this ...
In Germany, a COVID-19 vaccine damage claim will be defended by BioNTech
Source- BioNTech The COVID-19 vaccine partner of Pfizer, BioNTech, is going to court in its native Germany to defend itself ...
